J Pediatr Infect Dis 2022; 17(02): 098-105
DOI: 10.1055/s-0041-1741525
Original Article

Investigation of Antibiotic Susceptibility and Virulence Genes in Escherichia coli Strains Isolated from Blood and Urine Samples

1   Department of Medical Microbiology, Faculty of Medicine, Selcuk University, Konya, Turkey
,
1   Department of Medical Microbiology, Faculty of Medicine, Selcuk University, Konya, Turkey
,
Ugur Arslan
1   Department of Medical Microbiology, Faculty of Medicine, Selcuk University, Konya, Turkey
› Author Affiliations
Funding This study was supported by the Scientific Research Projects Coordinator of Selcuk University (grant number 19202025).

Abstract

Objective Extraintestinal Escherichia coli isolates are the most common gram-negative pathogens in humans and cause urinary tract infections, sepsis, neonatal meningitis, and others. The aim of this study was to investigate the rates of antibiotic resistance and virulence factors (kpsM II, neuc K1, hlyF, fyuA, afa/draBC, sat, chuA, fimH, tsh, yfcv, ibeA, traT, iucD, usp, iutA, cnf1, hlyA, papC, sfa/focDE, and ompT) of E. coli strains isolated from blood and urine samples.

Methods A total of 150 E. coli strains isolated from blood and urine samples sent to the Microbiology Laboratory, Faculty of Medicine Hospital, Selcuk University were included in the study. The identification and antibiotic susceptibility tests were performed with the VITEK 2 automated system. Multiplex polymerase chain reaction was used to detect the virulence genes.

Results Although the highest antibiotic resistance rate found was against ampicillin (73.3%), the lowest rates were against ertapenem and meropenem (0.7%). Extended-spectrum β-lactamase positivity was 38% in E. coli blood isolates and 29% in urine. The highest rates of virulence genes were detected in fimH gene (92%). iutA gene was 91.3%, traT 76%, fyuA 50%, chuA 54.7%, iucD 46.7%, ompT 32.7%, yfcv 31.3%, hlyF 28.7%, sat 22%, papC and sfa/focDE 20%, kpsM II 19.3%, neuc K1 14.7%, tsh 13.3%, cnf1 6.7%, afa/draBC 6%, ibeA 5.3%, usp 4.7%, and hlyA 3.3%. kpsM II, tsh, hlyA, papC, sfa/focDE, and ompT genes were higher in blood isolates.

Conclusion High antibiotic resistance rates and virulence genes were detected in E. coli strains in Konya, Turkey. This is the first study in Turkey where both a large number and a variety of virulence factors were investigated and compared. Multicenter studies are needed to better understand E. coli virulence.

Ethical Approval

This study was approved with the decision of the Ethics Committee of Faculty of Medicine, Selcuk University, numbered 2019/76.




Publication History

Received: 13 September 2021

Accepted: 07 December 2021

Article published online:
14 February 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Fratamico PM, DebRoy C, Liu Y, Needleman DS, Baranzoni GM, Feng P. Advances in molecular serotyping and subtyping of Escherichia coli . Front Microbiol 2016; 7: 644
  • 2 Lloyd AL, Henderson TA, Vigil PD, Mobley HL. Genomic islands of uropathogenic Escherichia coli contribute to virulence. J Bacteriol 2009; 191 (11) 3469-3481
  • 3 Koga VL, Tomazetto G, Cyoia PS. et al. Molecular screening of virulence genes in extraintestinal pathogenic Escherichia coli isolated from human blood culture in Brazil. BioMed Res Int 2014; 2014: 465054
  • 4 Subashchandrabose S, Mobley HLT. Virulence and fitness determinants of uropathogenic Escherichia coli . Microbiol Spectr 2015; 3 (04) 4
  • 5 Nataro JP, Bopp CA, Fields PI, Kaper JB, Strockbine NA. Escherichia, Shigella, Salmonella. In: Manual of Clinical Microbiology. 10th ed. Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW. eds. Washington, DC: ASM Press; 2011: 603-626
  • 6 Johnson JR, O'Bryan TT, Kuskowski M, Maslow JN. Ongoing horizontal and vertical transmission of virulence genes and papA alleles among Escherichia coli blood isolates from patients with diverse-source bacteremia. Infect Immun 2001; 69 (09) 5363-5374
  • 7 Ballesteros-Monrreal MG, Arenas-Hernández MM, Enciso-Martínez Y. et al. Virulence and resistance determinants of uropathogenic Escherichia coli strains isolated from pregnant and non-pregnant women from two states in Mexico. Infect Drug Resist 2020; 13: 295-310
  • 8 EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance Version 2.01. 2017 . Accessed November 23, 2021 at: http://www.eucast.org
  • 9 Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181 (01) 261-272
  • 10 Kaczmarek A, Skowron K, Budzyńska A, Gospodarek-Komkowska E. Virulence-associated genes and antibiotic susceptibility among vaginal and rectal Escherichia coli isolates from healthy pregnant women in Poland. Folia Microbiol (Praha) 2018; 63 (05) 637-643
  • 11 Ewers C, Li G, Wilking H. et al. Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: how closely related are they?. Int J Med Microbiol 2007; 297 (03) 163-176
  • 12 Lara FB, Nery DR, de Oliveira PM. et al. Virulence markers and phylogenetic analysis of Escherichia coli strains with hybrid EAEC/UPEC genotypes recovered from sporadic cases of extraintestinal infections. Front Microbiol 2017; 8: 146
  • 13 Tiba MR, Yano T, Leite DdaS. Genotypic characterization of virulence factors in Escherichia coli strains from patients with cystitis. Rev Inst Med Trop São Paulo 2008; 50 (05) 255-260
  • 14 Parajuli NP, Maharjan P, Parajuli H. et al. High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal. Antimicrob Resist Infect Control 2017; 6: 9
  • 15 Sağlam D, Durmaz S, Kılıç H. et al. Expanded spectrum beta-lactamase frequency and antibiotic resistance patterns in Escherichia coli strains isolated from blood cultures. Ankem Derg 2011; 25: 250-255
  • 16 Alqasim A, Jaffal AA, Almutairi N, Arshad M, Alyousef AA. Isolation, phenotypic and genotypic characterization of Escherichia coli from the bloodstream samples in Riyadh, Saudi Arabia. J King Saud Univ Sci 2020; 32: 1464-1469
  • 17 Çetinkol Y, Sandalli C, Çalgin MK. et al. High prevalence of NDM metallo-β-lactamase among ESBL-producing Escherichia coli isolates. Acta Microbiol Immunol Hung 2017; 64 (02) 131-141
  • 18 Najmi A, Karimi F, Kunhikatta V, Varma M, Nair S. Resistance trend, antibiotic utilization and mortality in patients with E. coli bacteraemia. Open Access Maced J Med Sci 2019; 7 (07) 1119-1123
  • 19 Taken K, Parlak M, Gunes M. et al. The urinary system infections caused by extended-spectrum-b-lactamase-producing Escherichia coli and Klebsiella pneumoniae Strains. East J Med 2016; 21: 31-35
  • 20 da Silva ACC, de Lima Feltraco Lizot L, Bastiani MF, Venzon Antunes M, Brucker N, Linden R. Dried plasma spots for therapeutic monitoring of amikacin: Validation of an UHPLC-MS/MS assay and pharmacokinetic application. J Pharm Biomed Anal 2020; 184: 113201
  • 21 Kayastha K, Dhungel B, Karki S. et al. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species in pediatric patients visiting International Friendship Children's Hospital, Kathmandu, Nepal. Infect Dis (Auckl) 2020; 13: 1178633720909798
  • 22 Ebrahimi S, Farhadian N, Karimi M, Ebrahimi M. Enhanced bactericidal effect of ceftriaxone drug encapsulated in nanostructured lipid carrier against gram-negative Escherichia coli bacteria: drug formulation, optimization, and cell culture study. Antimicrob Resist Infect Control 2020; 9 (01) 28
  • 23 Zorgani A, Almagatef A, Sufya N, Bashein A, Tubbal A. Detection of CTX-M-15 among uropathogenic Escherichia coli isolated from five major hospitals in Tripoli, Libya. Oman Med J 2017; 32 (04) 322-327
  • 24 Hernández-Vergara JA, Martínez-Santos VI, Radilla-Vázquez RB, Silva-Sánchez J, Vences-Velásquez A, Castro-Alarcón N. Characterization of Escherichia coli clinical isolates causing urinary tract infections in the community of Chilpancingo, Mexico. Int Microbiol 2016; 19 (04) 209-215
  • 25 Erdem I, Kara Ali R, Ardic E, Elbasan Omar S, Mutlu R, Topkaya AE. Community-acquired lower urinary tract infections: etiology, antimicrobial resistance, and treatment results in female patients. J Glob Infect Dis 2018; 10 (03) 129-132
  • 26 Mamani R, Flament-Simon SC, García V. et al. Sequence types, clonotypes, serotypes, and virotypes of extended-spectrum β-lactamase-producing Escherichia coli causing bacteraemia in a Spanish hospital over a 12-year period (2000 to 2011). Front Microbiol 2019; 10: 1530
  • 27 Chakraborty A, Adhikari P, Shenoy S, Saralaya V. Molecular characterisation of uropathogenic Escherichia coli isolates at a tertiary care hospital in South India. Indian J Med Microbiol 2017; 35 (02) 305-310
  • 28 Daga AP, Koga VL, Soncini JGM. et al. Escherichia coli bloodstream infection in patients at a university hospital: virulence factors and clinical characteristics. Front Cell Infect Microbiol 2019; 9: 191
  • 29 Hozzari A, Behzadi P, Kerishchi Khiabani P, Sholeh M, Sabokroo N. Clinical cases, drug resistance, and virulence genes profiling in uropathogenic Escherichia coli . J Appl Genet 2020; 61 (02) 265-273
  • 30 Valadbeigi H, Esmaeeli E, Ghafourian S, Maleki A, Sadeghifard N. Molecular analysis of uropathogenic E. coli isolates from urinary tract infections. Infect Disord Drug Targets 2019; 19 (03) 322-326
  • 31 Chen X, Zou Q, Zhang W, Wang R, Yu F, Chen Y. Clinical features and microbiological characteristics of hospital- and community-onset Escherichia coli bloodstream infection. J Med Microbiol 2019; 68 (02) 178-187
  • 32 Usein CR, Papagheorghe R, Oprea M, Condei M, Strãuţ M. Molecular characterization of bacteremic Escherichia coli isolates in Romania. Folia Microbiol (Praha) 2016; 61 (03) 221-226
  • 33 Cole BK, Ilikj M, McCloskey CB, Chavez-Bueno S. Antibiotic resistance and molecular characterization of bacteremia Escherichia coli isolates from newborns in the United States. PLoS One 2019; 14 (07) e0219352
  • 34 Ali I, Rafaque Z, Ahmed I. et al. Phylogeny, sequence-typing and virulence profile of uropathogenic Escherichia coli (UPEC) strains from Pakistan. BMC Infect Dis 2019; 19 (01) 620
  • 35 Johnson JR, Porter S, Johnston B. et al. Host characteristics and bacterial traits predict experimental virulence for Escherichia coli bloodstream isolates from patients with urosepsis. Open Forum Infect Dis 2015; 2 (03) ofv083
  • 36 Bozcal E, Eldem V, Aydemir S, Skurnik M. The relationship between phylogenetic classification, virulence and antibiotic resistance of extraintestinal pathogenic Escherichia coli in İzmir province, Turkey. PeerJ 2018; 6: e5470
  • 37 Safi M, Achour W, Baaboura R, El Fatmi R, Ben othmen T, Ben Hassen A. Distribution of virulence associated traits among urine Escherichia coli isolates from patients in onco-hematology. J Infect Chemother 2016; 22 (04) 221-224
  • 38 Hung WT, Cheng MF, Tseng FC. et al. Bloodstream infection with extended-spectrum beta-lactamase-producing Escherichia coli: the role of virulence genes. J Microbiol Immunol Infect 2019; 52 (06) 947-955
  • 39 Munkhdelger Y, Gunregjav N, Dorjpurev A, Juniichiro N, Sarantuya J. Detection of virulence genes, phylogenetic group and antibiotic resistance of uropathogenic Escherichia coli in Mongolia. J Infect Dev Ctries 2017; 11 (01) 51-57
  • 40 Jahandeh N, Ranjbar R, Behzadi P, Behzadi E. Uropathogenic Escherichia coli virulence genes: invaluable approaches for designing DNA microarray probes. Cent European J Urol 2015; 68 (04) 452-458